Table 3 The effect of statin use on COVID-19 patient survival as assessed by the crude, multivariable and propensity score analysis
From: Statins in patients with COVID-19: a retrospective cohort study in Iranian COVID-19 patients
| Cox models | Model | HR | 95% C.I for HR | P-value |
|---|---|---|---|---|
| Crude | 1 | 2.21 | 0.71–6.90 | 0.174 |
| Multivariate Cox | 2 | 0.92 | 0.21–4.16 | 0.918 |
| Weighted PH Cox (IPS as weight) | 3 | 0.94 | 0.22–4.17 | 0.923 |
| PH Cox after PS Matching | 4 | 0.85 | 0.02–3.93 | 0.762 |
| PH Cox adjusted with PS | 5 | 0.76 | 0.16–3.72 | 0.735 |